» Articles » PMID: 32964049

Deletion of Bmal1 Impairs Pancreatic -Cell Function Via Mitochondrial Signaling Pathway

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2020 Sep 23
PMID 32964049
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Several studies have demonstrated that brain and muscle Arnt-like protein-1 (Bmal1) acts as a core clock gene for maintaining normal cell function, including hepatocytes and cardiomyocytes. Loss of Bmal1 is associated with type 2 diabetes due to pancreatic -cell failure. However, little information is available about its role and mechanism in pancreatic -cell. To address this, we investigated the consequences of Bmal1 inhibition in an insulinoma cell line (INS-1) by using small interfering RNA (siRNA). We observed that knockout of Bmal1 impaired glucose-stimulated insulin secretion in -cell. Meanwhile, the depletion of Bmal1 in -cell caused an adverse change in mitochondrial membrane potential and mitochondrial architecture. Deletion of Bmal1 attenuated mRNA and protein expression of mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2) and enhanced the expression of fission 1 (Fis1). In summary, the deletion of Bmal1 impaired -cell function may be via the mitochondrial signaling pathway in INS-1 cells.

Citing Articles

Advancements in research on the association between the biological CLOCK and type 2 diabetes.

Cheng H, Zhong D, Tan Y, Huang M, Xijie S, Pan H Front Endocrinol (Lausanne). 2024; 15:1320605.

PMID: 38872971 PMC: 11169578. DOI: 10.3389/fendo.2024.1320605.


Defining diurnal fluctuations in mouse choroid plexus and CSF at high molecular, spatial, and temporal resolution.

Fame R, Kalugin P, Petrova B, Xu H, Soden P, Shipley F Nat Commun. 2023; 14(1):3720.

PMID: 37349305 PMC: 10287727. DOI: 10.1038/s41467-023-39326-3.


The role of circadian clock-controlled mitochondrial dynamics in diabetic cardiomyopathy.

Jin Z, Ji Y, Su W, Zhou L, Wu X, Gao L Front Immunol. 2023; 14:1142512.

PMID: 37215098 PMC: 10196400. DOI: 10.3389/fimmu.2023.1142512.


Association of BMAL1 clock gene polymorphisms with fasting glucose in children.

Yang Y, Zeng Y, Li J, Zhou J, He Q, Zheng C Pediatr Res. 2023; 94(2):653-659.

PMID: 36732647 PMC: 10382306. DOI: 10.1038/s41390-023-02467-8.


Importance of Bmal1 in Alzheimer's disease and associated aging-related diseases: Mechanisms and interventions.

Fan R, Peng X, Xie L, Dong K, Ma D, Xu W Aging Cell. 2022; 21(10):e13704.

PMID: 36056774 PMC: 9577946. DOI: 10.1111/acel.13704.


References
1.
Dong Z, Zhang G, Qu M, Gimple R, Wu Q, Qiu Z . Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock. Cancer Discov. 2019; 9(11):1556-1573. PMC: 6983300. DOI: 10.1158/2159-8290.CD-19-0215. View

2.
Jacobi D, Liu S, Burkewitz K, Kory N, Knudsen N, Alexander R . Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness. Cell Metab. 2015; 22(4):709-20. PMC: 4598294. DOI: 10.1016/j.cmet.2015.08.006. View

3.
Peek C, Affinati A, Ramsey K, Kuo H, Yu W, Sena L . Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science. 2013; 342(6158):1243417. PMC: 3963134. DOI: 10.1126/science.1243417. View

4.
Qiao L, Guo B, Zhang H, Yang R, Chang L, Wang Y . The clock gene, brain and muscle Arnt-like 1, regulates autophagy in high glucose-induced cardiomyocyte injury. Oncotarget. 2017; 8(46):80612-80624. PMC: 5655224. DOI: 10.18632/oncotarget.20811. View

5.
Thielen L, Shalev A . Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP. Curr Opin Endocrinol Diabetes Obes. 2018; 25(2):75-80. PMC: 5831522. DOI: 10.1097/MED.0000000000000391. View